127 related articles for article (PubMed ID: 3308589)
1. Physiological role of cholecystokinin in meal-induced insulin secretion in conscious rats. Studies with L 364718, a specific inhibitor of CCK-receptor binding.
Rossetti L; Shulman GI; Zawalich WS
Diabetes; 1987 Oct; 36(10):1212-5. PubMed ID: 3308589
[TBL] [Abstract][Full Text] [Related]
2. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
[TBL] [Abstract][Full Text] [Related]
3. Effects of three different cholecystokinin receptor antagonists on basal and stimulated insulin and glucagon secretion in mice.
Karlsson S; Ahrén B
Acta Physiol Scand; 1989 Mar; 135(3):271-8. PubMed ID: 2648765
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin is not a major determinant for the changes in beta-cell function seen after pancreatico-biliary diversion in rats.
Gasslander T; Lilja I; Smeds S; Lundquist I; Ihse I
Diabetes Res; 1991 Nov; 18(3):135-42. PubMed ID: 1841824
[TBL] [Abstract][Full Text] [Related]
5. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
6. Effects of cholecystokinin receptor blockade on circulating concentrations of glucose, insulin, C-peptide, and pancreatic polypeptide after various meals in healthy human volunteers.
Niederau C; Schwarzendrube J; Lüthen R; Niederau M; Strohmeyer G; Rovati L
Pancreas; 1992; 7(1):1-10. PubMed ID: 1557335
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cholecystokinin reduces feeding in young rats.
Weller A; Smith GP; Gibbs J
Science; 1990 Mar; 247(4950):1589-91. PubMed ID: 2321020
[TBL] [Abstract][Full Text] [Related]
8. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of cholecystokinin on isolated perifused islets inhibited by potent and specific antagonist L 364718 [corrected].
Zawalich WS; Diaz VA; Zawalich KC
Diabetes; 1988 Oct; 37(10):1432-7. PubMed ID: 3046973
[TBL] [Abstract][Full Text] [Related]
10. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans.
Verspohl EJ; Ammon HP; Williams JA; Goldfine ID
Diabetes; 1986 Jan; 35(1):38-43. PubMed ID: 3000856
[TBL] [Abstract][Full Text] [Related]
11. Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonist.
Pendleton RG; Bendesky RJ; Schaffer L; Nolan TE; Gould RJ; Clineschmidt BV
J Pharmacol Exp Ther; 1987 Apr; 241(1):110-6. PubMed ID: 2437283
[TBL] [Abstract][Full Text] [Related]
12. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
[TBL] [Abstract][Full Text] [Related]
13. Role of cholecystokinin in the inhibition of gastric acid secretion in dogs.
Konturek SJ; Bilski J; Tasler J; Cieszkowski M
J Physiol; 1992; 451():477-89. PubMed ID: 1403819
[TBL] [Abstract][Full Text] [Related]
14. CCKA receptor antagonism inhibits mechanisms underlying CCK-8-stimulated insulin release in isolated rat islets.
Karlsson S; Ahrén B
Eur J Pharmacol; 1991 Sep; 202(2):253-7. PubMed ID: 1666367
[TBL] [Abstract][Full Text] [Related]
15. The role of cholecystokinin (CCK8) on glucose production and elimination, and on plasma insulin and glucose in rats.
Verspohl EJ; Zoll C; Wahl MA; Ammon HP
Peptides; 1992; 13(6):1091-5. PubMed ID: 1494491
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenously released cholecystokinin in determining postprandial insulin levels in man: effects of loxiglumide, a specific cholecystokinin receptor antagonist.
Baum F; Nauck MA; Ebert R; Cantor P; Hoffmann G; Choudhury AR; Schmidt WE; Creutzfeldt W
Digestion; 1992; 53(3-4):189-99. PubMed ID: 1291406
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
[TBL] [Abstract][Full Text] [Related]
18. Peptide receptor antagonists in the study of insulin and glucagon secretion in mice.
Karlsson S; Ahrén B
Eur J Pharmacol; 1990 Dec; 191(3):457-64. PubMed ID: 1964911
[TBL] [Abstract][Full Text] [Related]
19. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
Hosotani R; Chowdhury P; Rayford PL
Dig Dis Sci; 1989 Mar; 34(3):462-7. PubMed ID: 2646088
[TBL] [Abstract][Full Text] [Related]
20. CCK-8-stimulated insulin secretion in vivo is mediated by CCKA receptors.
Karlsson S; Ahrén B
Eur J Pharmacol; 1992 Mar; 213(1):145-6. PubMed ID: 1499651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
